RankAlpha logo
Back to Rankings

IFRX

InflaRxF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
IFRX vs peer average
24/100
IFRX vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PALI is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $322.86M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPALIPalisade Bio
IFRX
InflaRx
PALI
Palisade Bio
Grade
F
B
Momentum
17
85
Value
41
41
Sentiment
-
55
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs PALI

IFRX / PALI
Grade Position
Below peers
IFRX vs. peer average (F vs. C)
24/100
Momentum
17
PALI
Value
41
IFRX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IFRX
1
PALI
Palisade Bio Inc Common
B
80/100
-3
2
RCKT
Rocket Pharmaceuticals Inc Common
C
60/100
-2
3
NMRA
Neumora Therapeutics Inc Common
A
100/100
-4
4
ABEO
Abeona Therapeutics Inc Common
B
80/100
-3
5
IRD
Opus Genetics Inc Common
F
20/100
Even
PALI is the first peer returned for this comparison set.